AJP - Lung Cellular and Molecular Physiology, Vol 264, Issue 3 236-L244, Copyright © 1993 by American Physiological Society

ARTICLES

Biphasic glucocorticoid regulation of pulmonary SP-A: characterization of inhibitory process

D. M. Iannuzzi, R. Ertsey and P. L. Ballard
Department Pediatrics, University of California, San Francisco 19143.

Pulmonary surfactant, which is necessary for normal lung function, is under both developmental and hormonal regulation. Glucocorticoids induce all components of surfactant and have a unique biphasic effect on surfactant protein A (SP-A), either stimulating or inhibiting accumulation in cultured fetal lung depending on dose and time of exposure. In this study we further characterized glucocorticoid inhibition of SP-A in cultured explants of human fetal lung. Decreased content of SP-A mRNA was the dominant response to dexamethasone added either early or later during culture. Inhibition occurred at < or = 1 nM dexamethasone on prolonged exposure, was blocked by RU 486, and was observed with other glucocorticoids but not sex steroids. When cortisol was removed from the culture medium, inhibition was rapidly reversed. The immediate inhibitory effect of 100 nM dexamethasone on SP-A mRNA content was completely blocked in the presence of cycloheximide. SP-A gene transcription, measured by nuclear elongation assay, was decreased by 60% after 4- to 8-h exposure to 100 nM dexamethasone. Stability of SP-A mRNA, determined both by addition of actinomycin D and by label-chase experiments, was transiently decreased immediately after adding dexamethasone (t1/2 approximately 3 h). In tissue treated with dexamethasone for > or = 8 h the stability of SP-A mRNA in control and treated explants was not different (t1/2 approximately 8 h). Our findings indicate that inhibition of SP-A is the dominant response to glucocorticoid. This effect is receptor mediated and apparently involves induction of a labile protein(s) that decreases gene transcription and transiently reduces mRNA stability.

This article has been cited by other articles:

				G. Wang, X. Guo, and J. Floros Differences in the translation efficiency and mRNA stability mediated by 5'-UTR splice variants of human SP-A1 and SP-A2 genes Am J Physiol Lung Cell Mol Physiol, September 1, 2005; 289(3): L497 - L508. [Abstract] [Full Text] [PDF]

				J. L. Alcorn, K. N. Islam, P. P. Young, and C. R. Mendelson Glucocorticoid inhibition of SP-A gene expression in lung type II cells is mediated via the TTF-1-binding element Am J Physiol Lung Cell Mol Physiol, April 1, 2004; 286(4): L767 - L776. [Abstract] [Full Text] [PDF]

				G. Wang, X. Guo, and J. Floros Human SP-A 3'-UTR variants mediate differential gene expression in basal levels and in response to dexamethasone Am J Physiol Lung Cell Mol Physiol, May 1, 2003; 284(5): L738 - L748. [Abstract] [Full Text] [PDF]

				V. Glumoff, O. Väyrynen, T. Kangas, and M. Hallman Degree of Lung Maturity Determines the Direction of the Interleukin-1- Induced Effect on the Expression of Surfactant Proteins Am. J. Respir. Cell Mol. Biol., March 1, 2000; 22(3): 280 - 288. [Abstract] [Full Text]

				R. C. Tan, M. Ikegami, A. H. Jobe, L. Y. Yao, F. Possmayer, and P. L. Ballard Developmental and glucocorticoid regulation of surfactant protein mRNAs in preterm lambs Am J Physiol Lung Cell Mol Physiol, December 1, 1999; 277(6): L1142 - L1148. [Abstract] [Full Text] [PDF]

				R. R. Hoover and J. Floros SP-A 3'-UTR is involved in the glucocorticoid inhibition of human SP-A gene expression Am J Physiol Lung Cell Mol Physiol, June 1, 1999; 276(6): L917 - L924. [Abstract] [Full Text] [PDF]

				L. M. Scavo, R. Ertsey, and B. Q. Gao Human surfactant proteins A1 and A2 are differentially regulated during development and by soluble factors Am J Physiol Lung Cell Mol Physiol, October 1, 1998; 275(4): L653 - L669. [Abstract] [Full Text] [PDF]

				T. N. George, O. L. Miakotina, K. L. Goss, and J. M. Snyder Mechanism of all trans-retinoic acid and glucocorticoid regulation of surfactant protein mRNA Am J Physiol Lung Cell Mol Physiol, April 1, 1998; 274(4): L560 - L566. [Abstract] [Full Text] [PDF]

				M. J. Acarregui, A. R. Kumar, S. T. Penisten, and J. M. Snyder O2 regulates surfactant protein A mRNA transcription and stability in human fetal lung in vitro Am J Physiol Lung Cell Mol Physiol, March 1, 1998; 274(3): L343 - L350. [Abstract] [Full Text] [PDF]

				J. M. Shannon, T. Pan, K. E. Edeen, and L. D. Nielsen Influence of the cytoskeleton on surfactant protein gene expression in cultured rat alveolar type II cells Am J Physiol Lung Cell Mol Physiol, January 1, 1998; 274(1): L87 - L96. [Abstract] [Full Text] [PDF]

				P. L. Ballard, Y. Ning, D. Polk, M. Ikegami, and A. H. Jobe Glucocorticoid regulation of surfactant components in immature lambs Am J Physiol Lung Cell Mol Physiol, November 1, 1997; 273(5): L1048 - L1057. [Abstract] [Full Text] [PDF]

				J. Vyas and S. Kotecha Effects of antenatal and postnatal corticosteroids on the preterm lung Arch. Dis. Child. Fetal Neonatal Ed., September 1, 1997; 77(2): 147F - 150. [Full Text]

				P. A. Iredale and R. S. Duman Glucocorticoid Regulation of Corticotropin-Releasing Factor1 Receptor Expression in Pituitary-Derived AtT-20 Cells Mol. Pharmacol., May 1, 1997; 51(5): 794 - 799. [Abstract] [Full Text]